Tag: Indian Immunologicals
Indian Immunologicals receives regulatory approval for Measles-Rubella vaccine
This vaccine has been proven through extensive human clinical trials to be immunogenic and safe for people of 9 months to 49 years
Indian Immunologicals continues its venture in fish vaccine development, signs agreement...
The company partners with Central Institute of Freshwater Aquaculture (CIFA), an Indian Council of Agricultural Research Institute for the commercial development of vaccine against Hemorrhagic Septicemia in freshwater fishes
Indian Immunologicals launches its first set of virtual medical representatives
The Hyderabad based subsidiary of National Dairy Development Board (NDDB) has been in the forefront of business process innovation
Indian Immunologicals’ FMD Vaccine becomes world’s first animal vaccine to be...
Drone delivery of vaccines is expected to not only reach remote difficult terrains faster but also help in providing critical vaccines on time
Indian Immunologicals to invest Rs 700 crore in Hyderabad for new...
The company is investing in a new greenfield project for the establishment of a Veterinary Vaccine Facility for manufacturing of Foot and Mouth Disease (FMD) vaccine and other animal vaccines
Indian Immunologicals forays into aquaculture health segment
The company’s foray into aquaculture segment will be in multiple phases comprising of multiple products including vaccines
Indian Immunologicals to expand New Zealand operations
Company's subsidiary Pristine Biologicals NZ inaugurated New Sterile Filtered Serum manufacturing facility in Dargaville, New Zealand
Indian Immunologicals launches vaccine for Goat Pox
The prevalence rate of Goat pox varies according to agroclimatic zones and may be up to 48% in certain parts as per a study
Govt lauds Indian Immunologicals for producing COVID-19 drug substance in record...
Due to IIL’s prior experience in producing different types of viral vaccines for human and veterinary use, it could upgrade the existing facility and execute technology transfer, manufacturing, testing, and release of drug substances at lightning speed................
Indian Immunologicals to produce 3-4 million Covaxin drug substance per month
Output of Covaxin drug substance will be 3 to 4 million a month and from December will increase to 10 million a month...........................